A deep technical development, with potentially far-reaching, albeit not obvious repercussions. That's how we could summarize today's announcement by Chainlink, regarding the upgrade in its network.

A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers. Objectives: Matching the supply ...